![Ronald Rooke](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ronald Rooke
No más puestos en curso
Perfil
Ronald Rooke had founded ElsaLys Biotech SAS in 2013 and held the title of Head-Target Discovery department.
Antiguos cargos conocidos de Ronald Rooke.
Empresas | Cargo | Fin |
---|---|---|
ELSALYS BIOTECH | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
ElsaLys Biotech SAS
![]() ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology ElsaLys Biotech SAS provides therapeutic monoclonal antibody player services. It involves in cellular events at the core of the pathological process: immune response, angiogenesis, survival, proliferation, adhesion and migration. The company also designs and develops a new generation of antibodies that target tumors and their immune microenvironment. ElsaLys Biotech was founded by Christine Guillen, Thierry Menguy, Vanessa Duong, and Martine Brandt in 2013 and is headquartered in Lyon, France. | Health Technology |
- Bolsa de valores
- Insiders
- Ronald Rooke